Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan
· Delayed Price · Currency is JPY 1,661.00
+42.50 (2.63%)
Mar 10, 2026, 3:24 PM JST
Santen Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 61,544 | 92,997 | 94,582 | 57,903 | 83,014 | 62,888 | Upgrade
|
| Cash & Short-Term Investments | 61,544 | 92,997 | 94,582 | 57,903 | 83,014 | 62,888 | Upgrade
|
| Cash Growth | -20.95% | -1.68% | 63.35% | -30.25% | 32.00% | -31.22% | Upgrade
|
| Accounts Receivable | 68,620 | 71,759 | 90,539 | 107,165 | 99,591 | 95,992 | Upgrade
|
| Other Receivables | 730 | 324 | - | 60 | - | - | Upgrade
|
| Receivables | 69,350 | 72,083 | 90,539 | 107,225 | 99,591 | 95,992 | Upgrade
|
| Inventory | 60,071 | 51,590 | 43,185 | 39,352 | 37,141 | 41,575 | Upgrade
|
| Other Current Assets | 12,142 | 7,630 | 7,833 | 8,846 | 9,680 | 5,776 | Upgrade
|
| Total Current Assets | 203,107 | 224,300 | 236,139 | 213,326 | 229,426 | 206,231 | Upgrade
|
| Property, Plant & Equipment | 77,054 | 72,954 | 71,576 | 66,173 | 56,287 | 39,489 | Upgrade
|
| Long-Term Investments | - | 26,539 | 33,400 | 42,560 | 40,944 | 40,933 | Upgrade
|
| Goodwill | - | 8,242 | 8,303 | 7,385 | 13,715 | 26,858 | Upgrade
|
| Other Intangible Assets | 77,477 | 67,225 | 75,516 | 88,924 | 116,502 | 86,018 | Upgrade
|
| Long-Term Deferred Tax Assets | 10,176 | 10,017 | 10,765 | 2,810 | 3,103 | 2,824 | Upgrade
|
| Other Long-Term Assets | 33,347 | - | - | 1 | -1 | - | Upgrade
|
| Total Assets | 401,161 | 409,277 | 435,699 | 421,179 | 459,976 | 402,353 | Upgrade
|
| Accounts Payable | 32,854 | 38,989 | 43,531 | 44,945 | 41,185 | 38,106 | Upgrade
|
| Accrued Expenses | - | 6,514 | 7,792 | - | - | - | Upgrade
|
| Short-Term Debt | - | 274 | 54 | 245 | 10,936 | - | Upgrade
|
| Current Portion of Leases | - | 3,015 | 2,694 | 2,811 | 3,029 | 2,912 | Upgrade
|
| Current Income Taxes Payable | 2,156 | 3,029 | 5,710 | 6,745 | 4,198 | 5,458 | Upgrade
|
| Other Current Liabilities | 40,655 | 35,016 | 33,015 | 34,758 | 36,473 | 32,073 | Upgrade
|
| Total Current Liabilities | 75,665 | 86,837 | 92,796 | 89,504 | 95,821 | 78,549 | Upgrade
|
| Long-Term Debt | - | 26,483 | 26,915 | 28,198 | 12,677 | 2,400 | Upgrade
|
| Long-Term Leases | - | 4,457 | 4,947 | 4,953 | 6,290 | 4,834 | Upgrade
|
| Pension & Post-Retirement Benefits | 1,433 | 1,221 | 1,292 | 1,271 | 1,077 | 1,210 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2,983 | 2,606 | 1,377 | 1,592 | 2,526 | 3,290 | Upgrade
|
| Other Long-Term Liabilities | 38,644 | 2,492 | 3,002 | 2,365 | 4,742 | 5,020 | Upgrade
|
| Total Liabilities | 118,725 | 124,096 | 130,329 | 127,883 | 123,133 | 95,303 | Upgrade
|
| Common Stock | 8,819 | 8,806 | 8,777 | 8,702 | 8,672 | 8,525 | Upgrade
|
| Additional Paid-In Capital | 9,364 | 9,797 | 9,854 | 9,789 | 9,370 | 8,954 | Upgrade
|
| Retained Earnings | 205,635 | 228,291 | 240,029 | 238,071 | 290,477 | 270,757 | Upgrade
|
| Treasury Stock | -978 | -1,161 | -1,018 | -364 | -718 | -934 | Upgrade
|
| Comprehensive Income & Other | 60,542 | 40,509 | 48,413 | 37,781 | 29,687 | 20,283 | Upgrade
|
| Total Common Equity | 283,382 | 286,242 | 306,055 | 293,979 | 337,488 | 307,585 | Upgrade
|
| Minority Interest | -946 | -1,061 | -685 | -683 | -645 | -535 | Upgrade
|
| Shareholders' Equity | 282,436 | 285,181 | 305,370 | 293,296 | 336,843 | 307,050 | Upgrade
|
| Total Liabilities & Equity | 401,161 | 409,277 | 435,699 | 421,179 | 459,976 | 402,353 | Upgrade
|
| Total Debt | - | 34,229 | 34,610 | 36,207 | 32,932 | 10,146 | Upgrade
|
| Net Cash (Debt) | 61,544 | 58,768 | 59,972 | 21,696 | 50,082 | 52,742 | Upgrade
|
| Net Cash Growth | -20.95% | -2.01% | 176.42% | -56.68% | -5.04% | -33.32% | Upgrade
|
| Net Cash Per Share | 184.67 | 168.06 | 162.91 | 56.00 | 125.06 | 131.73 | Upgrade
|
| Filing Date Shares Outstanding | 321.67 | 337.56 | 356.09 | 369.88 | 393.3 | 399.82 | Upgrade
|
| Total Common Shares Outstanding | 321.67 | 341.36 | 363.21 | 375.54 | 400.27 | 399.82 | Upgrade
|
| Working Capital | 127,442 | 137,463 | 143,343 | 123,822 | 133,605 | 127,682 | Upgrade
|
| Book Value Per Share | 880.97 | 838.52 | 842.64 | 782.82 | 843.15 | 769.31 | Upgrade
|
| Tangible Book Value | 205,905 | 210,775 | 222,236 | 197,670 | 207,271 | 194,709 | Upgrade
|
| Tangible Book Value Per Share | 640.11 | 617.45 | 611.87 | 526.36 | 517.83 | 486.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.